From Headaches to Heartbreak: A Nottingham Family’s Battle with Glioblastoma
Andrew Hayes, a 61-year-old from Nottingham, initially dismissed his headaches as a symptom of sleep apnoea. This common misdiagnosis highlights a critical challenge in early cancer detection – the subtlety of initial symptoms. It wasn’t until severe head pain prompted a visit to Queen’s Medical Centre in July 2025 that a CT scan revealed a devastating truth: a brain tumour.
The Aggressive Nature of Glioblastoma
Further investigation, including an MRI scan, led doctors to suspect a glioma. Following surgery to remove as much of the tumour as possible, the diagnosis was confirmed: glioblastoma, an aggressive and incurable form of brain cancer. This diagnosis carries a particularly grim prognosis, with a typical life expectancy of 12 to 18 months.
Initial Symptoms Often Overlooked
Andrew’s daughter, Kirsten Lowe, a finance manager, recounts how the early signs were easily missed. “My mum, Lisa, and sister, Lily, noticed he seemed more tired than usual, and when the headaches started, we thought it was sleep apnoea or a migraine.” This underscores the importance of being vigilant about persistent or worsening symptoms and seeking medical attention promptly.
The Emotional Toll on Families
The impact of a glioblastoma diagnosis extends far beyond the patient. Kirsten describes the heartbreak of receiving the prognosis: “It was heart-breaking. When we were given his prognosis of 12 to 18 months, I couldn’t accept it. I couldn’t face knowing my dad had been given such a short amount of time to live.” The emotional strain on families is immense, requiring significant support, and resilience.
Treatment and Ongoing Challenges
Andrew underwent six weeks of radiotherapy and chemotherapy at City Hospital in Nottingham. When this initial treatment proved ineffective, he began a different chemotherapy regimen, with scan results pending to assess its success. The disease has already led to memory loss, increased fatigue, and a loss of independence, forcing him to give up driving and his job.
A Daughter’s Determination: The National Three Peaks Challenge
Driven by a desire to turn helplessness into action, Kirsten Lowe is undertaking the National Three Peaks Challenge to raise funds for Brain Tumour Research. She hopes to support research at the latest Brain Tumour Research Centre of Excellence at the University of Nottingham, where scientists are utilizing advanced techniques like artificial intelligence and genomic analysis to improve glioblastoma treatment.
The Importance of Research and Innovation
The Centre of Excellence is focused on understanding glioblastoma recurrence and accelerating the development of more effective therapies. Kirsten believes that supporting this research offers hope for the future, stating, “Knowing that researchers…are working to better understand and treat glioblastoma gives us hope.”
Frequently Asked Questions
- What is glioblastoma? Glioblastoma is an aggressive type of cancer that can occur in the brain.
- What are the common symptoms of glioblastoma? Symptoms can include headaches, fatigue, memory loss, and changes in personality.
- Is glioblastoma curable? Currently, glioblastoma is considered incurable, but research is ongoing to develop more effective treatments.
- How can I support Brain Tumour Research? You can donate to organizations like Brain Tumour Research or participate in fundraising events.
Did you know? Glioblastoma is the most common and aggressive malignant primary brain tumour in adults.
To support Kirsten’s National Three Peaks Challenge fundraiser, visit here.
